Objective Factors for Classifying Weapons With “Stabilizing Braces”; Withdrawal of Guidance
| Published date | 31 December 2020 |
| Citation | 85 FR 86948 |
| Record Number | 2020-28930 |
| Section | Notices |
| Court | Alcohol, Tobacco, Firearms, And Explosives Bureau,Justice Department |
86948
Federal Register / Vol. 85, No. 251 / Thursday, December 31, 2020 / Notices
Commission’s rules; the deadline for
filing is February 26, 2021. Parties may
also file written testimony in connection
with their presentation at the hearing, as
provided in § 207.24 of the
Commission’s rules, and posthearing
briefs, which must conform with the
provisions of § 207.25 of the
Commission’s rules. The deadline for
filing posthearing briefs is March 11,
2021. In addition, any person who has
not entered an appearance as a party to
the investigations may submit a written
statement of information pertinent to
the subject of the investigations,
including statements of support or
opposition to the petition, on or before
March 11, 2021. On March 25, 2021, the
Commission will make available to
parties all information on which they
have not had an opportunity to
comment. Parties may submit final
comments on this information on or
before March 29, 2021, but such final
comments must not contain new factual
information and must otherwise comply
with § 207.30 of the Commission’s rules.
All written submissions must conform
with the provisions of § 201.8 of the
Commission’s rules; any submissions
that contain BPI must also conform with
the requirements of §§ 201.6, 207.3, and
207.7 of the Commission’s rules. The
Commission’s Handbook on Filing
Procedures, available on the
Commission’s website at https://
www.usitc.gov/documents/handbook_
on_filing_procedures.pdf, elaborates
upon the Commission’s procedures with
respect to filings.
Additional written submissions to the
Commission, including requests
pursuant to § 201.12 of the
Commission’s rules, shall not be
accepted unless good cause is shown for
accepting such submissions, or unless
the submission is pursuant to a specific
request by a Commissioner or
Commission staff.
In accordance with §§ 201.16(c) and
207.3 of the Commission’s rules, each
document filed by a party to the
investigations must be served on all
other parties to the investigations (as
identified by either the public or BPI
service list), and a certificate of service
must be timely filed. The Secretary will
not accept a document for filing without
a certificate of service.
Authority: These investigations are being
conducted under authority of title VII of the
Tariff Act of 1930; this notice is published
pursuant to § 207.21 of the Commission’s
rules.
By order of the Commission.
Issued: December 28, 2020.
William Bishop,
Supervisory Hearings and Information
Officer.
[FR Doc. 2020–28986 Filed 12–30–20; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Bureau of Alcohol, Tobacco, Firearms,
and Explosives
[Docket No. 2020R–10W]
Objective Factors for Classifying
Weapons With ‘‘Stabilizing Braces’’;
Withdrawal of Guidance
AGENCY
: Bureau of Alcohol, Tobacco,
Firearms, and Explosives, Department of
Justice.
ACTION
: Notice; withdrawal.
SUMMARY
: The Bureau of Alcohol,
Tobacco, Firearms, and Explosives
(‘‘ATF’’) is announcing the withdrawal
of a notice and request for comments
entitled ‘‘Objective Factors for
Classifying Weapons with ‘Stabilizing
Braces’,’’ that was published on
December 18, 2020.
DATES
: The withdrawal is effective
December 31, 2020.
ADDRESSES
: This Notice also will be
made available on the ATF website
(www.atf.gov).
FOR FURTHER INFORMATION CONTACT
:
Andrew Lange, Office of Regulatory
Affairs, Enforcement Programs and
Services, Bureau of Alcohol, Tobacco,
Firearms, and Explosives, U.S.
Department of Justice, 99 New York
Ave. NE, Mail Stop 6N–518,
Washington, DC 20226; telephone: (202)
648–7070 (this is not a toll-free
number).
SUPPLEMENTARY INFORMATION
: Upon
further consultation with the
Department of Justice and the Office of
the Deputy Attorney General, ATF is
withdrawing, pending further
Department of Justice review, the notice
and request for comments entitled
‘‘Objective Factors for Classifying
Weapons with ‘Stabilizing Braces’,’’ that
was published on December 18, 2020.
85 FR 82516. As explained in the notice,
the proposed guidance was not a
regulation. The notice informed and
invited comment from the industry and
public on a proposed guidance prior to
issuing a final guidance document.
The withdrawal of the guidance does
not change any law, regulation, or other
legally binding requirement.
Marvin G. Richardson,
Associate Deputy Director.
[FR Doc. 2020–28930 Filed 12–30–20; 8:45 am]
BILLING CODE 4410–FY–P
DEPARTMENT OF JUSTICE
Antitrust Division
United States, et al. v. Harvard Pilgrim
Health Care, Inc., et al.; Proposed Final
Judgment and Competitive Impact
Statement
Notice is hereby given pursuant to the
Antitrust Procedures and Penalties Act,
15 U.S.C. 16(b)–(h), that a proposed
Final Judgment, Stipulation, and
Competitive Impact Statement have
been filed with the United States
District Court for the District of New
Hampshire in United States and State of
New Hampshire vs. Harvard Pilgrim
Health Care, Inc. and Health Plan
Holdings, Inc., Civil Action No. 1:20–
cv–01183. On December 14, 2020, the
United States filed a Complaint alleging
that the proposed merger of Harvard
Pilgrim Health Care, Inc. and Health
Plan Holdings, Inc. (f/k/a Tufts Health
Plan, Inc.) would violate Section 7 of
the Clayton Act, 15 U.S.C. 18. The
proposed Final Judgment, filed at the
same time as the Complaint, requires
Health Plan Holdings to divest its New
Hampshire subsidiary, Tufts Health
Freedom Plans, Inc., along with certain
tangible and intangible assets.
Copies of the Complaint, proposed
Final Judgment, and Competitive Impact
Statement are available for inspection
on the Antitrust Division’s website at
http://www.justice.gov/atr and at the
Office of the Clerk of the United States
District Court for the District of New
Hampshire. Copies of these materials
may be obtained from the Antitrust
Division upon request and payment of
the copying fee set by Department of
Justice regulations.
Public comment is invited within 60
days of the date of this notice. Such
comments, including the name of the
submitter, and responses thereto, will be
posted on the Antitrust Division’s
website, filed with the Court, and, under
certain circumstances, published in the
Federal Register. Comments should be
directed to Eric D. Welsh, Chief,
Healthcare and Consumer Products
Section, Antitrust Division, Department
of Justice, 450 Fifth Street NW, Suite
VerDate Sep<11>2014 19:28 Dec 30, 2020 Jkt 253001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 E:\FR\FM\31DEN1.SGM 31DEN1
khammond on DSKJM1Z7X2PROD with NOTICES
